A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 480
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : CE
Long Form : contrast-enhanced
No. Year Title Co-occurring Abbreviation
2019 7T CEST MRI: A potential imaging tool for the assessment of tumor grade and cell proliferation in breast cancer. ADC, CEST, DC, DWI, GRE, MTRasym
2019 Added Value of Contrast Medium in Whole-Body Hybrid PET/MRI: Comparison Between Contrast-Enhanced and Non-Contrast-Enhanced Protocols. NCE
2019 Analyzing the post-contrast attenuation of the esophageal wall on routine contrast-enhanced MDCT examination can improve the diagnostic accuracy in response evaluation of the squamous cell esophageal carcinoma to neoadjuvant chemoradiotherapy in comparison with the esophageal wall thickness. ESCC, MDCT, nCRT, pCR, TRG
2019 Apparent diffusion coefficient and tumor volume measurements help stratify progression-free survival of bevacizumab-treated patients with recurrent glioblastoma multiforme. ADC, GBM, OS, PFS, VPC
2019 Arterial spin labeling perfusion-weighted imaging aids in prediction of molecular biomarkers and survival in glioblastomas. ASL-PWI, CBF, GBM, IDH, MGMT, NE, OS, PFS
2019 Assessment of the myocardial area at risk: comparing T2-weighted cardiovascular magnetic resonance imaging with contrast-enhanced cine (CE-SSFP) imaging-a DANAMI3 substudy. AAR, CMR, LV, T2-STIR
2019 Association Between Supratotal Glioblastoma Resection and Patient Survival: A Systematic Review and Meta-Analysis. CIs, GBM, GTR, HRs, SPTR
2019 Automated quantitative tumour response assessment of MRI in neuro-oncology with artificial neural networks: a multicentre, retrospective study. ANNs, EORTC, NEs, RANO
2019 Background parenchymal enhancement assessment: Inter- and intra-rater reliability across breast MRI sequences. BPE, MIP
10  2019 Biopsy and Ablation of H3K27 Glioma Using Skull-Mounted Smartframe Device: Technical Case Report. SLA, VPS
11  2019 Breath-hold [68Ga]DOTA-TOC PET/CT in neuroendocrine tumors: detection of additional lesions and effects on quantitative parameters. fbPET, NET, SUV
12  2019 Characterizing tumor invasiveness of glioblastoma using multiparametric magnetic resonance imaging. Cho, CI, Cr, DTI, HR, Lac, MRS, OS, PFS, rCBV, RIC, ROIs
13  2019 Comparison of contrast-enhanced and diffusion-weighted MRI in assessment of the terminal ileum in Crohn's disease patients. CDEIS, DW
14  2019 CT-Detected Extramural Vessel Invasion and Regional Lymph Node Involvement in Stage T4a Gastric Cancer for Predicting Progression-Free Survival. EMVI, PFS
15  2019 Diagnosis of spinal metastasis: are MR images without contrast medium application sufficient? MRI
16  2019 Double-inversion recovery with synthetic magnetic resonance: a pilot study for assessing synovitis of the knee joint compared to contrast-enhanced magnetic resonance imaging. DIR, MRI, SI
17  2019 Dynamic Contrast-enhanced Area-detector CT vs Dynamic Contrast-enhanced Perfusion MRI vs FDG-PET/CT: Comparison of Utility for Quantitative Therapeutic Outcome Prediction for NSCLC Patients Undergoing Chemoradiotherapy. ADCT, NSCLC, OS, RECIST
18  2019 Dynamics of brain perfusion and cognitive performance in revascularization of carotid artery stenosis. ASL, ASL-CBF, CE-CBF
19  2019 Echocardiographic assessment of myocardial function and mechanics during veno-venous extracorporeal membrane oxygenation. ECMO, TTE, UE
20  2019 Effect of Vitamin D supplementation on synovial tissue volume and subchondral bone marrow lesion volume in symptomatic knee osteoarthritis. BML, MRI, STV
21  2019 Enhancement of the Marginal Area in Colorectal Cancer Liver Metastasis on Computed Tomography Correlates With Microvessel Density and Clinicopathological Factors. CT, MVD, ROI
22  2019 Estimation of split renal function using different volumetric methods: inter- and intraindividual comparison between MRI and CT. CT, MELV, RCV, SRF
23  2019 Evaluation of suspected musculoskeletal infection in children over 2years of age using only fluid-sensitive sequences at MRI. CE study, MSK
24  2019 Frequency and predictors of detecting early locoregional recurrence/disease progression of oral squamous cell carcinoma with high-risk factors on imaging tests before postoperative adjuvant radiotherapy. LR/DP
25  2019 Influence of intravenous contrast agent on dose calculation in proton therapy using dual energy CT. DECT, MLIC, NC, SECT, SPR, VNC
26  2019 Longitudinal characterization of intervertebral disc remodeling following acute annular injury in a rat model of degenerative disc disease. AF, CT, IVD, NP
27  2019 Morphological MRI-based features provide pretreatment survival prediction in glioblastoma. C-indexes
28  2019 MR textural analysis on contrast enhanced 3D-SPACE images in assessment of consistency of pituitary macroadenoma. MRTA, PMA
29  2019 MR-Based Radiomics Nomogram of Cervical Cancer in Prediction of the Lymph-Vascular Space Invasion preoperatively. CI, LVSI, ROC
30  2019 MRA versus DSA for the follow-up imaging of intracranial aneurysms treated using endovascular techniques: a meta-analysis. DSA, FD, MRA, SAC, TOF
31  2019 Multi-parametric and multi-regional histogram analysis of MRI: modality integration reveals imaging phenotypes of glioblastoma. HR, NE, OS, PFS
32  2019 Multi-parametric effect in predicting tumor histological grade by using susceptibility weighted magnetic resonance imaging in tongue squamous cell carcinoma. CE-SWI, ITSSs, OTSCCs, SWI
33  2019 Non-contrast-enhanced magnetic resonance imaging for visualization and quantification of endovascular aortic prosthesis, their endoleaks and aneurysm sacs at 1.5 T. CE-CTA, DSA, EVAR, QISS-MRA
34  2019 Potential Complementary Value of Noncontrast and Contrast Enhanced CT Radiomics in Colorectal Cancers. CT, NCE, rs
35  2019 Pre-operative MRI predictors of hormonal remission status post pituitary adenoma resection. CISS, ICA, VIBE, WI
36  2019 Preoperative evaluation of small bowel complications in Crohn's disease: comparison of diffusion-weighted and contrast-enhanced MR imaging. CD, DW, MRE, WI
37  2019 Quantitative analysis of cochlear signal intensity on three-dimensional and contrast-enhanced fluid-attenuated inversion recovery images in patients with Meniere's disease: Correlation with the pure tone audiometry test. 3D-FLAIR, CEI, CER, MD, MRI, PTA, ROI, SI
38  2019 Radiomic signature as a predictive factor for lymph node metastasis in early-stage cervical cancer. CI, LNM, ROC-AUC
39  2019 Radiomics model of contrast-enhanced MRI for early prediction of acute pancreatitis severity. AP, APACHE, AUC, BISAP, CT, MRSI
40  2019 Solitary pulmonary nodule: Comparison of quantitative capability for differentiation and management among dynamic CE-perfusion MRI at 3 T system, dynamic CE-perfusion ADCT and FDG-PET/CT. ADCT, ROC, SPNs
41  2019 The features of cerebral permeability and perfusion detected by dynamic contrast-enhanced magnetic resonance imaging with Patlak model in relapsing-remitting multiple sclerosis. CBF, CBV, DCE-MRI, EDSS, MS, NAWM, NE, RRMS, Vp
42  2019 Virtual monoenergetic images from spectral detector CT as a surrogate for conventional CT images: Unaltered attenuation characteristics with reduced image noise. CI, NCE, Q-IodMap, SDCT, VMI
43  2018 Added Value of Contrast-Enhanced T1-Weighted and Diffusion-Weighted Sequences for Characterization of Incidental Findings on Whole Body Magnetic Resonance Imaging in Plasma-Cell Disorders. DWI, T1W, WB-MRI
44  2018 Assessing venous thrombus in renal cell carcinoma: preliminary results for unenhanced 3D-SSFP MRI. CNR, cRCC, CT, IVC, MRI, T2-HASTE
45  2018 C-Arm Cone Beam CT for Intraprocedural Image Fusion and 3D Guidance in Portal Vein Embolization (PVE). CBCT, DAP, PVE, US
46  2018 Clinical Evaluation of a Multiparametric Deep Learning Model for Glioblastoma Segmentation Using Heterogeneous Magnetic Resonance Imaging Data From Clinical Routine. DSC, GB, MRI
47  2018 Combination of CT angiography and MRI in surgical planning of deep brain stimulation. CTA, DBS
48  2018 Comparison of Constructive Interference in Steady-State and T1-Weighted MRI Sequence at Detecting Pituitary Adenomas in Cushing's Disease Patients. CD, CISS, MRI, VIBE
49  2018 Comparison of epicardial adipose tissue radiodensity threshold between contrast and non-contrast enhanced computed tomography scans: A cohort study of derivation and validation. CT, EAT, HU, NC
50  2018 Contrast-enhanced cadaver-specific computed tomography in gross anatomy teaching. CEPMCT, NE, PMCT
51  2018 Contrast-enhanced cone-beam breast-CT (CBBCT): clinical performance compared to mammography and MRI. ACR, AUC, BI-RADS, CBBCT, CBBCT, MG, MRI, NC, US
52  2018 Correlation between microcirculation and contrast-enhanced ultrasonography after crush injury of limbs. ---
53  2018 CT diagnosis of gallbladder adenomyomatosis: importance of enhancing mucosal epithelium, the "cotton ball sign". GA, GB, WTs
54  2018 Early Changes in Tumor Perfusion from T1-Weighted Dynamic Contrast-Enhanced MRI following Neural Stem Cell-Mediated Therapy of Recurrent High-Grade Glioma Correlate with Overall Survival. OS, Vp
55  2018 Extending the resection beyond the contrast-enhancement for glioblastoma: feasibility, efficacy, and outcomes. FLAIR, GBM
56  2018 Fast acquisition cone-beam computed tomography: initial experience with a 10 s protocol. CBCT
57  2018 First-in-human intraoperative near-infrared fluorescence imaging of glioblastoma using cetuximab-IRDye800. MFI, TBRs
58  2018 Gadobutrol: A Review in Contrast-Enhanced MRI and MRA. CV, GBCA, NSF
59  2018 Gd contrast administration is dispensable in patients with MS without new T2 lesions on follow-up MRI. FLAIR, Gd
60  2018 Imaging cellularity in benign and malignant peripheral nerve sheath tumors: Utility of the "target sign" by diffusion weighted imaging. ADC, BPNSTs, DWI, ICC, MPNSTs, PNST
61  2018 Intraoperative Photodynamic Diagnosis Using Talaporfin Sodium Simultaneously Applied for Photodynamic Therapy against Malignant Glioma: A Prospective Clinical Study. NCE, PDD, PDT, TS
62  2018 Less radiation, same quality: contrast-enhanced multi-detector computed tomography investigation of thoracic lymph nodes with one milli-sievert. IASLC
63  2018 Magnetic Resonance Imaging in degenerative disease of the lumbar spine: Fat Saturation technique and contrast medium. FS, FS
64  2018 Mandibular canal visibility using a plain volumetric interpolated breath-hold examination sequence in MRI. NVB, VIBEs
65  2018 Measurement of the permeability, perfusion, and histogram characteristics in relapsing-remitting multiple sclerosis using dynamic contrast-enhanced MRI with extended Tofts linear model. CBF, CBV, DCE-MRI, EDSS, MRI, MS, NAWM, NE, RRMS, Ve, Vp
66  2018 Non-enhanced versus low-dose contrast-enhanced renal magnetic resonance angiography at 7 T: a feasibility study. CNR, CR, FLASH, Gd, MRA, NSF, SNR
67  2018 Non-ionic iodinated contrast-induced sialadenitis with parotid gland sparing in patient of hepatocellular carcinoma. HCC
68  2018 Phantom-based study exploring the effects of different scatter correction approaches on the reconstructed images generated by contrast-enhanced stationary digital breast tomosynthesis. sDBT
69  2018 Quantification accuracy for dynamic contrast enhanced (DCE) CT imaging: phantom and quality assurance framework. DCE, QA
70  2018 Radiogenomics Profiling for Glioblastoma-related Immune Cells Reveals CD49d Expression Correlation with MRI parameters and Prognosis. ADC, GBM, TAMs
71  2018 Recurrent pseudoprogression in isocitrate dehydrogenase 1 mutant glioblastoma. 18F-FET-PET, CMRI, GBM, IDH1, PsP, RANO
72  2018 Role of contrast-enhanced 18F-FDG PET/CT imaging in the diagnosis and staging of renal tumors. F-FDG
73  2018 Single-Shot Coronary Quiescent-Interval Slice-Selective Magnetic Resonance Angiography Using Compressed Sensing: A Feasibility Study in Patients With Congenital Heart Disease. CHD, CS, MRA, QISS
74  2018 Stewart-Treves syndrome: Magnetic resonance imaging data compared with pathological results from a single center. AS, LE, mLAS, MRI, SI, STS
75  2018 T2* Mapping to characterize intestinal fibrosis in crohn's disease. AUC, CD, ROC
76  2018 The effect of glioblastoma heterogeneity on survival stratification: a multimodal MR imaging texture analysis. GBM, MR, T1W, T2W
77  2018 Usefulness of contrast-enhanced and TOF MR angiography for follow-up after low-profile stent-assisted coil embolization of intracranial aneurysms. DSA, LBS, MRA, TOF
78  2018 Utility of volumetric contrast-enhanced and diffusion-weighted MRI in differentiating between common primary hypervascular liver tumors. ADC, ANOVA, DWI, FNH, HCA, HCC, ROC
79  2018 Which Parameter Is More Important for the Prognosis of New-Onset Adult Glioblastoma: Residual Tumor Volume or Extent of Resection? EOR, MRI, OS, PFS, RTV
80  2017 Aggressive resection at the infiltrative margins of glioblastoma facilitated by intraoperative fluorescein guidance. GBM, GTR, NCE
81  2017 Application of BI-RADS Descriptors in Contrast-Enhanced Dual-Energy Mammography: Comparison with MRI. CEDEM, MRI
82  2017 Associations Between Clinical Evidence of Inflammation and Synovitis in Symptomatic Knee Osteoarthritis: A Cross-Sectional Substudy. KOA, MRI, VIDEO, WOMAC
83  2017 Breath-hold and free-breathing F-18-FDG-PET/CT in malignant melanoma-detection of additional tumoral foci and effects on quantitative parameters. bhPET, fbPET, SUV
84  2017 Characterization of indeterminate soft tissue masses referred for biopsy: What is the added value of contrast imaging at 3.0 tesla? ADC, AUC, DWI, non-CE-MR sequences, STMs
85  2017 Characterization of Metabolic, Diffusion, and Perfusion Properties in GBM: Contrast-Enhancing versus Non-Enhancing Tumor. GBM
86  2017 Clinical utility of optimized three-dimensional T1-, T2-, and T2*-weighted sequences in spinal magnetic resonance imaging. AVF, AVM, DSA, FA, FSE, GE, MRA, MRI, SNR, SSFP
87  2017 Comparison among conventional and advanced MRI, 18F-FDG PET/CT, phenotype and genotype in glioblastoma. ADC, FA, GB, GSCs, LL, MRI, NE, PET/CT, rCBV
88  2017 Comparison of T2-weighted imaging, diffusion-weighted imaging and contrast-enhanced T1-weighted MR imaging for evaluating perianal fistulas. ---
89  2017 Contrast-induced nephropathy (CIN) of patients with renal dysfunction in CT examination. CI, CIN, CT, eGFR, ICU, OR, SCr
90  2017 Could parenchymal enhancement on contrast-enhanced spectral mammography (CESM) represent a new breast cancer risk factor? Correlation with known radiology risk factors. BI-RADS, BPE, CESM, FFDM, FGTV, MBD, MRI
91  2017 CT imaging of solid renal masses: pitfalls and solutions. AML, CT, DECT, HC, MRI, NECT, RCC
92  2017 Diagnostic accuracy of different magnetic resonance imaging sequences for detecting local tumor progression after radiofrequency ablation of hepatic malignancies. DWI, RF, VIBE
93  2017 Differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma using magnetic resonance imaging: The value of contrast-enhanced and diffusion weighted imaging. ADC, DWI, MRI, PDAC, PNEC
94  2017 Direct comparison of PET/CT and MRI to predict the pathological response to neoadjuvant chemotherapy in breast cancer: a meta-analysis. CI, NAC
95  2017 Dynamic Contrast-Enhanced Perfusion Area-Detector CT: Preliminary Comparison of Diagnostic Performance for N Stage Assessment With FDG PET/CT in Non-Small Cell Lung Cancer. ADCT, NSCLC
96  2017 Effect of injection rate on contrast-enhanced MR angiography image quality: Modulation transfer function analysis. ---
97  2017 ESUR recommendations for MR imaging of the sonographically indeterminate adnexal mass: an update. ---
98  2017 Evaluation of obliteration of arteriovenous malformations after stereotactic radiosurgery with arterial spin labeling MR imaging. ASL, AV, AVMs, DSA, MR, SRS
99  2017 Glioblastoma: does the pre-treatment geometry matter? A postcontrast T1 MRI-based study. GBM, HR, OS
100  2017 Hepatocellular carcinoma detection: diagnostic performance of a simulated abbreviated MRI protocol combining diffusion-weighted and T1-weighted imaging at the delayed phase post gadoxetic acid. AMRI, DWI, HBP, HCC, NPV, T1W